Current Edition

Dupixent

On a roll, Sanofi raises Dupixent’s peak sales target to €13B-plus

Over the years, as Sanofi and Regeneron’s Dupixent racked up new indications and approached the French pharma giant’s 10 billion euro peak sales goal, analysts had started …

Continue Reading →